| CRISPR Therapeutics AG. (11/20/19). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA. |
2019-11-20 |
| Sophia Genetics S.A.. (11/20/19). "Press Release: Sophia Genetics Welcomes Milton Silva-Craig to Its Board of Directors". Boston, MA & Lausanne. |
2019-11-20 |
| CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. |
2019-11-19 |
| CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001 for Severe Hemoglobinopathies". Zug |
2019-11-19 |
| Vaximm AG. (11/12/19). "Press Release: NEC and Vaximm Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines". Tokyo, Basel & Mannheim. |
2019-11-12 |
| Lonza Group Ltd.. (11/12/19). "Press Release: Board Announcement". Basel. |
2019-11-12 |
| Genedata AG. (11/12/19). "Press Release: Immatics Implements Genedata Biologics into Proprietary T-Cell Receptor Discovery and Engineering XCEPTOR Platform". Basel. |
2019-11-12 |
| Evotec SE. (11/6/19). "Press Release: Evotec and Vifor Pharma Form Joint Venture for Early Development in Nephrology". Hamburg & St. Gallen. |
2019-11-06 |
| ADC Therapeutics S.A.. (11/5/19). "Press Release: ADC Therapeutics Appoints Jennifer Herron as Chief Commercial Officer". Lausanne. |
2019-11-05 |
| Santhera Pharmaceuticals AG. (11/4/19). "Press Release: Santhera Appoints New Chief Executive Officer". Pratteln. |
2019-11-04 |
| Xlife Sciences AG. (11/4/19). "Press Release: Xlife Siences AG. New Project in the Portfolio". Zurich. |
2019-11-04 |
| Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel. |
2019-10-31 |
| CRISPR Therapeutics AG. (10/28/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results". Zug & Cambridge, MA. |
2019-10-28 |
| CRISPR Therapeutics AG. (10/21/19). "Press Release: CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics". Leverkusen, Zug & Cambridge, MA. |
2019-10-21 |
| Arcutis Biotherapeutics, Inc.. (10/21/19). "Press Release: Arcutis Announces the Completion of $94.5 Million Series C Financing". Westlake Village, CA. |
2019-10-21 |
| Numab Therapeutics AG. (10/15/19). "Press Release: Numab Appoints Daniel Vasella to Board of Directors". Wädenswil (Zurich). |
2019-10-15 |
| CRISPR Therapeutics AG. (10/15/19). "Press Release: CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology". Zug & Cambridge, MA. |
2019-10-15 |
| Roivant Sciences GmbH. (10/9/19). "Press Release: Parexel and Datavant Enter Multi-Year Strategic Partnership to Enable the Connection of Real-World Data Across All Parexel Clinical Trials". Boston, MA & San Francisco, CA. |
2019-10-09 |
| LeadXPro AG. (10/7/19). "Press Release: LeadXPro and Lundbeck enter Strategic Partnership on Membrane Protein Structure Research". Villigen. |
2019-10-07 |
| ADC Therapeutics S.A.. (10/2/19). "Press Release: ADC Therapeutics Announces Withdrawal of Registration Statement". Lausanne. |
2019-10-02 |
| Numab Therapeutics AG. (10/1/19). "Press Release: Numab and Eisai Enter into a Global Research and Option Agreement to Discover and Develop Multi-specific Antibody Immunotherapies for Cancer". Tokyo & Zurich. |
2019-10-01 |
| Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich). |
2019-09-30 |
| T3 Pharmaceuticals AG. (9/26/19). "Press Release: Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic". |
2019-09-26 |
| Addex Therapeutics S.A.. (9/24/19). "Press Release: Addex Therapeutics Submits Registration Statement with the U.S. SEC to Facilitate Nasdaq Listing of ADSs Representing Shares". Geneva. |
2019-09-24 |
| ADC Therapeutics S.A.. (9/23/19). "Press Release: ADC Therapeutics Announces Launch of Initial Public Offering". Lausanne. |
2019-09-23 |
| AC Immune S.A.. (9/20/19). "Press Release: AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer Program". Lausanne. |
2019-09-20 |
| Novigenix S.A.. (9/19/19). "Press Release: Novigenix and BioLizard Sign Collaboration Agreement for Development of NGS Based Diagnostic Algorithm". Lausanne. |
2019-09-19 |
| Versantis AG. (9/18/19). "Press Release: Versantis Closes CHF 16M Series B Financing Round to Advance Clinical Development of Novel Therapeutics for Liver Diseases". Zürich. |
2019-09-18 |
| Roche. (9/18/19). "Press Release: FDA Grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis". Basel. |
2019-09-18 |
| CRISPR Therapeutics AG. (9/17/19). "Press Release: CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019". Zug, Cambridge, MA & San Diego, CA. |
2019-09-17 |
| AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne. |
2019-09-17 |
| Bruker Corporation. (9/16/19). "Press Release: Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF Pro Platform at HUPO 2019". Adelaide. |
2019-09-16 |
| Abionic S.A.. (9/13/19). "Press Release: International Pivotal Study Successfully Demonstrates Diagnosis of Sepsis within 5 Minutes – 24 Hours Earlier Compared with Current Standard-of-Care". Lausanne. |
2019-09-13 |
| Genedata AG. (9/11/19). "Press Release: Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative". Basel. |
2019-09-11 |
| ADC Therapeutics S.A.. (9/6/19). "Press Release: ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering". Lausanne. |
2019-09-06 |
| Novartis AG. (9/6/19). "Press Release: Novartis Investigational Lung Cancer Therapy Capmatinib (INC280) Granted FDA Breakthrough Therapy Designation for Patients with MET-mutated Advanced Non-small Cell Lung Cancer". Basel. |
2019-09-06 |
| Abionic S.A.. (9/5/19). "Press Release: Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests". Lausanne. |
2019-09-05 |
| AC Immune S.A.. (9/4/19). "Press Release: AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent". Lausanne. |
2019-09-04 |
| Roche. (9/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. |
2019-09-03 |
| Novartis AG. (9/3/19). "Press Release: Sandoz Announces Global Deal to Commercialize Proposed Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine". Holzkirchen. |
2019-09-03 |
| Tecan Group Ltd.. (8/30/19). "Press Release: Tania Micki to Succeed Long-time CFO Rudolf Eugster in Q1 2020 with effect from 2019 Annual Financial Statements". Männedorf. |
2019-08-30 |
| Lunaphore Technologies S.A.. (8/30/19). "Press Release: Lunaphore Appoints Joseph Bernardo as New Chairman of the Board". Lausanne. |
2019-08-30 |
| Novartis AG. (8/30/19). "Press Release: Novartis Ofatumumab Demonstrates Superiority versus Aubagio in Two Head-to-head Phase III Multiple Sclerosis Studies". Basel. |
2019-08-30 |
| Roche. (8/29/19). "Press Release: European Commission Approves Roche’s Tecentriq in Combination with Abraxane for People with PD-L1-positive, Metastatic Triple-negative Breast Cancer". Basel. |
2019-08-29 |
| Bruker Corporation. (8/26/19). "Press Release: Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data". Berlin. |
2019-08-26 |
| ADC Therapeutics S.A.. (8/26/19). "Press Release: ADC Therapeutics and Freenome Enter Biomarker Development Collaboration". Lausanne & South San Francisco, CA. |
2019-08-26 |
| Idorsia Ltd.. (8/23/19). "Press Release: Clinical Data on Idorsia’s Pipeline Compounds Will Be Presented at the European Society of Cardiology Congress 2019". Allschwil. |
2019-08-23 |
| Cytosurge AG. (8/21/19). "Press Release: Cytosurge AG Announces Spin-off of Its 3D Printing Business Unit". Glattbrugg. |
2019-08-21 |
| Araris Biotech AG. (8/20/19). "Press Release: Araris Biotech AG Closes Seed Financing Round of CHF 2.5 Million". Zurich. |
2019-08-20 |
| Roche. (8/16/19). "Press Release: FDA Approves Roche’s Rozlytrek (entrectinib) for People with ROS1-positive, MMetastatic Non-small Cell Lung Cancer and NTRK Gene Fusion-positive Solid Tumours". Basel. |
2019-08-16 |
| Tecan Group Ltd.. (8/15/19). "Press Release: H1 2019 – Tecan Again Posts Significant Increase in Sales, Driven by Strong Growth in the Life Sciences Business". Männedorf. |
2019-08-15 |
| Pharming Group N.V.. (8/13/19). "Press Release: Pharming Acquires Exclusive License to CDZ173, a Late Stage Drug for the Treatment of APDS". Leiden. |
2019-08-13 |
| AC Immune S.A.. (8/12/19). "Press Release: AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases". Lausanne. |
2019-08-12 |
| ADC Therapeutics S.A.. (8/6/19). "Press Release: ADC Therapeutics and Sophia Genetics Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial". Lausanne. |
2019-08-06 |
| GNA Biosolutions GmbH. (8/5/19). "Press Release: GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium". Munich. |
2019-08-05 |
| Roche. (8/5/19). "Press Release: Roche’s Tecentriq plus Platinum-based Chemotherapy Reduced the Risk of Disease Worsening or Death in People with Previously Untreated Advanced Bladder Cancer". Basel. |
2019-08-05 |
| Quanta Dialysis Technologies Ltd.. (7/29/19). "Press Release: Quanta Raises $48 million in Series C Funding Round". Alcester, Warwickshire. |
2019-07-29 |
| Freenome, Inc.. (7/24/19). "Press Release: Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection". South San Francisco, CA. |
2019-07-24 |
| Gilead Sciences, Inc.. (7/19/19). "Press Release: Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis". Foster City, CA. |
2019-07-19 |
| Novartis AG. (7/16/19). "Press Release: FDA Accepts File and Accelerates Review of Novartis Sickle Cell Disease Medicine Crizanlizumab (SEG101)". Basel. |
2019-07-16 |
| Boehringer Ingelheim. (7/15/19). "Press Release: Boehringer Ingelheim Acquires Amal Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform". Ingelheim & Geneva. |
2019-07-15 |
| Novartis AG. (7/11/19). "Press Release: Novartis, Amgen and Banner Alzheimer's Institute Discontinue Clinical Program with BACE inhibitor CNP520 for Alzheimer's Prevention". Basel. |
2019-07-11 |
| Genedata AG. (7/9/19). "Press Release: Genedata Biopharma Platform Adopted by Genmab to Streamline Biotherapeutics R&D Operations". Basel. |
2019-07-09 |
| Cytosurge AG. (7/9/19). "Press Release: Olympus Europe and Cytosurge Partner to Enhance Pharma Drug Development and Single Cell Research". Zurich / Glattbrugg & Hamburg. |
2019-07-09 |
| ADC Therapeutics S.A.. (7/9/19). "Press Release: ADC Therapeutics Announces Final Close of Series E Financing Expansion". Lausanne. |
2019-07-09 |
| Bruker Corporation. (7/8/19). "Press Release: Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC". Zurich. |
2019-07-08 |
| Mack Brooks Exhibitions Ltd.. (7/8/19). "Press Release: Trend Barometer Chemspec Europe 2019 Closes with Record in Visitor Numbers and Exhibition Space". |
2019-07-08 |
| Genedata AG. (7/2/19). "Press Release: Genedata and AB Enzymes Expand Partnership to Digitalize Strain Development". Basel. |
2019-07-02 |
| Illumina, Inc.. (6/28/19). "Press Release: Illumina Files Patent Infringement Suits Related to BGI in Switzerland, Turkey and the US". San Diego, CA. |
2019-06-28 |
| Polyphor Ltd.. (6/27/19). "Press Release: Polyphor Appoints Frank Weber as New Chief Medical and Development Officer". Allschwil. |
2019-06-27 |
| Genedata AG. (6/25/19). "Press Release: Genedata Expands Collaboration with AstraZeneca on Deep Learning for High-Content Image Analysis". Basel. |
2019-06-25 |
| Selexis S.A.. (6/20/19). "Press Release: Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing". Cambridge & Geneva. |
2019-06-20 |
| Lonza Group Ltd.. (6/19/19). "Press Release: Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel". Basel & Boston, MA. |
2019-06-19 |
| Hesperos, Inc.. (6/19/19). "Press Release: Human-on-a-chip Model Enables Simultaneous Testing of Cancer Drug Efficacy and Off-Target Toxicity to Enable Determination of Therapeutic Index". Orlando, FL. |
2019-06-19 |
| Roche. (6/18/19). "Press Release: Japan Becomes the First Country to Approve Roche’s Personalised Medicine Rozlytrek". Basel. |
2019-06-18 |
| ADC Therapeutics S.A.. (6/12/19). "Press Release: ADC Therapeutics Announces Completion of a Series E Financing Expansion. Brings Total Raised in the Series E Round to $276 Million". Lausanne. |
2019-06-12 |
| Debiopharm International SA. (6/12/19). "Press Release: Debiopharm and Ipsen Extend Their Strategic Decapeptyl (triptorelin) Partnership for another 15 Years". Lausanne & Paris. |
2019-06-12 |
| Lunaphore Technologies S.A.. (6/10/19). "Press Release: Cartana, Lunaphore and Stockholm University Collaborate on Automated Next Generation In Situ Sequencing". Stockholm & Lausanne. |
2019-06-10 |
| Sanofi S.A.. (6/7/19). "Press Release: Paul Hudson to Succeed Olivier Brandicourt as Chief Executive Officer". Paris. |
2019-06-07 |
| Vertex Pharmaceuticals Inc.. (6/6/19). "Press Release: Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics". Boston, MA & Watertown, |
2019-06-06 |
| Genedata AG. (6/4/19). "Press Release: Genedata Expressionist 13.0 Streamlines In-depth Characterization and Automates Quality Monitoring of Biopharmaceuticals". Atlanta, GA. |
2019-06-04 |
| LeadXPro AG. (6/3/19). "Press Release: LeadXPro and Astex Enter Strategic Partnership on Membrane Protein Strcuture Research". Cambridge & Villigen. |
2019-06-03 |
| Tecan Group Ltd.. (5/31/19). "Press Release: Tecan Successfully Completes the Acquisition of Supplier of Key Parts". Männedorf. |
2019-05-31 |
| Polyphor Ltd.. (5/29/19). "Press Release: Polyphor and the University of Zurich Receive an Award from Innosuisse to Accelerate the Development of a New Class of Antibiotics Inhibiting the LPS Transport Pathway". Allschwil. |
2019-05-29 |
| Owlstone Medical Ltd.. (5/20/19). "Press Release: Owlstone Medical Enters into a Strategic Collaboration with Actelion to Develop a Breath-Based Test to Help Facilitate Early Detection of Pulmonary Hypertension". Cambridge. |
2019-05-20 |
| Polyphor Ltd.. (5/17/19). "Press Release: Polyphor Announces Presentation of New Survival Data on Balixafortide at the ASCO Annual Meeting 2019". Allschwil. |
2019-05-17 |
| Roche. (5/16/19). "Press Release: Roche’s Personalised Medicine Entrectinib Shrank Tumours Harbouring NTRK, ROS1 or ALK Gene Fusions in Children and Adolescents". Basel. |
2019-05-16 |
| Roche. (5/16/19). "Press Release: Roche Announces FDA Approval for Venclexta plus Gazyva for People with Previously Untreated Chronic Lymphocytic Leukaemia". Basel. |
2019-05-16 |
| Roche. (5/15/19). "Press Release: Roche Reports Very Strong Performance in the First Half of 2019 – Outlook Raised". Philadeliphia, PA & Oxfordshire. |
2019-05-15 |
| Medigene AG. (5/14/19). "Press Release: Medigene Reports Financial & Business Results for the First Three Months of 2019". Martinsried. |
2019-05-14 |
| Debiopharm International SA. (5/14/19). "Press Release: Debiopharm Awarded $2.1 Million from CARB-X in the Fight against a Highly Resistant Nosocomial-pneumonia Causing Superbug". Lausanne. |
2019-05-14 |
| Polyphor Ltd.. (5/9/19). "Press Release: Polyphor Temporarily Halts Enrollment in the Phase III Studies of Murepavadin for the Treatment of Patients with Nosocomial Pneumonia". Allschwil. |
2019-05-09 |
| Pfizer Inc.. (5/8/19). "Press Release: Pfizer Acquires Clinical-Stage Biotech Therachon". New York, NY & Basel. |
2019-05-08 |
| SGS S.A.. (5/3/19). "Press Release: SGS Acquires Chemical Solutions Ltd., USA". |
2019-05-03 |
| Amal Therapeutics S.A.. (5/2/19). "Press Release: Amal Therapeutics Enters Clinical Collaboration with Boehringer Ingelheim to Evaluate ATP128 in Combination with BI754091". Geneva. |
2019-05-02 |
| Numab Therapeutics AG. (5/2/19). "Press Release: CStone and Numab Announce Exclusive Regional Licensing Agreement for ND021, a Multi-functional Drug Candidate and Potential Next-generation Immunotherapy". Suzhou & Pfäffikon. |
2019-05-02 |
| Genedata AG. (5/2/19). "Press Release: Out-of-the-Box Integration of Genedata Bioprocess with MODDE Streamlines Bioprocess Development DOE". Basel. |
2019-05-02 |
| SGS S.A.. (4/30/19). "Press Release: SGS Implements Veeva Vault Clinical Trial Management System across its Global Network". |
2019-04-30 |
| Alentis Therapeutics AG. (4/30/19). "Press Release: Alentis Therapeutics Launches, Raising CHF 12.5m in a Series A to Develop Novel Therapeutics in Advanced Liver Disease and Cancer". Basel. |
2019-04-30 |
| CRISPR Therapeutics AG. (4/29/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results". Zug & Cambridge, MA. |
2019-04-29 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
